D. Eric Mendelsohn Acquires 1,500 Shares of National Health Investors (NYSE:NHI) Stock

National Health Investors, Inc. (NYSE:NHI) CEO D. Eric Mendelsohn bought 1,500 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was purchased at an average price of $68.84 per share, with a total value of $103,260.00. Following the purchase, the chief executive officer directly owned 133,316 shares of the company’s stock, valued at $9,177,473.44. The trade was a 1.14% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

National Health Investors Price Performance

Shares of NYSE:NHI traded up $1.94 during trading on Friday, reaching $70.26. The stock had a trading volume of 70,008 shares, compared to its average volume of 338,838. National Health Investors, Inc. has a 52 week low of $67.94 and a 52 week high of $91.38. The business’s 50-day moving average price is $78.59 and its 200 day moving average price is $80.38. The company has a debt-to-equity ratio of 0.83, a current ratio of 8.20 and a quick ratio of 8.20. The stock has a market capitalization of $3.41 billion, a PE ratio of 22.66, a P/E/G ratio of 3.63 and a beta of 0.52.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Monday, May 4th. The real estate investment trust reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.39). The company had revenue of $115.13 million during the quarter, compared to analyst estimates of $70.22 million. National Health Investors had a net margin of 36.86% and a return on equity of 9.82%. The business’s revenue for the quarter was up 28.9% on a year-over-year basis. During the same period in the prior year, the business earned $1.15 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. As a group, equities analysts predict that National Health Investors, Inc. will post 5.07 earnings per share for the current year.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be issued a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.68 dividend on an annualized basis and a dividend yield of 5.2%. National Health Investors’s dividend payout ratio (DPR) is currently 118.71%.

Institutional Trading of National Health Investors

A number of institutional investors have recently bought and sold shares of NHI. International Assets Investment Management LLC acquired a new stake in National Health Investors during the 4th quarter worth $27,000. EverSource Wealth Advisors LLC grew its holdings in National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after acquiring an additional 288 shares during the period. Garton & Associates Financial Advisors LLC acquired a new stake in National Health Investors during the 4th quarter worth $33,000. GAMMA Investing LLC grew its holdings in National Health Investors by 41.8% during the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after acquiring an additional 136 shares during the period. Finally, Key Capital Management INC acquired a new stake in National Health Investors during the 4th quarter worth $47,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on NHI. Weiss Ratings reissued a “buy (b)” rating on shares of National Health Investors in a report on Friday, March 27th. Cantor Fitzgerald reissued an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. Truist Financial lowered their price target on shares of National Health Investors from $92.00 to $89.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Finally, Wells Fargo & Company lowered their price target on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a report on Monday. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $86.67.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.